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Relationship between pre-sarcopenia, 
sarcopenia and bone mineral 
density in elderly men 
Fernando Borges Pereira1, André Ferreira Leite2, Ana Patrícia de Paula3 
ABSTRACT
Objective: Analyze the influence of sarcopenia in bone health of elderly men. Subjects and me­
thods: This cross-sectional study evaluated 198 men aged over 60 years. Body composition was 
measured by dual energy X-ray absorptiometry. The BMD was measured at the femoral neck, total 
hip, lumbar spine and 33% radius. The diagnosis of abnormal BMD was defined for men who pre-
sented densitometric diagnosis of osteopenia or osteoporosis defined by T-score of femoral neck, to-
tal hip and lumbar spine. The pre-sarcopenia and sarcopenia were defined according to the European 
Working Group on Sarcopenia in Older People. Results: The group diagnosed with normal BMD, 
compared to the group of abnormal BMD, have significantly higher body weight, body mass index, 
grip strength, lean mass, fat mass, and relative appendicular skeletal muscle mass (RASM). However, 
after multiple linear regression analysis, we found that only the RASM, lean mass, and handgrip 
strength in the dominant hand influenced the variability of the BMD after adjustment for age and 
weight. Regression analyzes showed a positive association between greater appendicular lean mass 
and a smaller number of elderly patients with abnormal BMD diagnostic. The regression analyzes 
showed that elderly men diagnosed with pre-sarcopenia and sarcopenia had more abnormal BMD 
than non-sarcopenic elderly men. Conclusion: We concluded that pre-sarcopenia and sarcopenia 
were associated with abnormal BMD. The lean mass, compared to fat mass, has a greater positive 
influence on the BMD of elderly men. This result suggests the importance of the increase in lean mass 
for the bone health of elderly men. Arch Endocrinol Metab. 2015;59(1):59-65
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O steoporosis is a major public health problem in the male population (1). Total costs including 
prevalent fractures are more than $19 billion in the 
United States. Men account for 29% of fractures and 
25% of costs (2).
Sarcopenia has emerged as an important risk factor 
for osteoporosis (3,4). In addition to increasing falls 
risk, sarcopenia might also decrease bone strength by 
reducing mechanical loading to the skeleton. Reduc-
tion of mechanical stimulation could result from de-
creased maximal force that weaker muscles produce 
and/or less time that the skeleton is loaded due to rela-
tive immobility, and thus bone formation is reduced (5-7). 
The evidence for this relationship comes primarily from 
observational epidemiological studies in women (5,7). 
However, the available data regarding this association 
are inconsistent, mainly due to a lack of definition in 
the diagnosis of sarcopenia (8,9). 
Recently, the European Working Group on Sar-
copenia in Older People (EWGSOP) suggested cri-
teria and sub-classifications for a definition of sarco-
penia, which are based not only on the assessment of 
the reduction in fat-free mass but also on the assess-
ment of loss of muscle strength and physical perfor-
mance (8). 
Few studies have evaluated the influence of sarco-
penia as diagnosed by the setting EWGSOP in bone 
mineral density (BMD) in older men. Elucidating this 
relationship will enable the development of more effec-
tive strategies for the prevention of osteoporosis in the 
male population.
The aim of this study is analyze the influence of sar-
copenia in bone health of elderly men using the more 
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MATERIALS AND METHODS
Subjects
The present study included healthy men aged over or 
equal to 60 years from a community in São Sebastião-
Federal District, Brazil. Subjects institutionalized or 
in active bone therapies (corticosteroids, bisphospho-
nates, parathyroid hormone, calcium and vitamin D) 
were excluded from the study. Subjects using medica-
tion or having a disease like rheumatoid arthritis, in-
flammatory myopathy, prolonged immobilization, or 
cancer were also excluded. 
We tried to contact five hundred and twenty four 
elderly men with a history of vaccination in the São Se-
bastião’s health center (Federal District, Brazil). Only 
265 elderly men with a valid telephone were found. 
Seventeen men refused to participate in the study and 
five had died. Two hundred and forty three men were 
initially evaluated, 226 met the inclusion and exclu-
sion criteria, and 198 underwent bone densitometry by 
DXA for assessment of bone mineral density and body 
composition and muscle strength evaluation.
The 198 elderly men were evaluated for the pres-
ence of clinical risk factors for osteoporotic fracture 
like eating habits, smoking, alcohol consumption, as-
sociated diseases, medications, and family and personal 
history of fragility fractures. The patients underwent all 
reviews in less than 60 days. All participants agreed and 
signed the consent form. The Research Ethics Com-
mittee of the Faculty of Health Sciences, University of 
Brasilia, approved the study.
A scale with stadiometer Filizola® assessed weight 
and height. Body mass index (BMI) was calculated di-
viding weight in kilograms by height in meters squared.
Dual energy X-ray absorptiometry (DXA) for bone 
parameters and body composition analysis
Bone densitometry by DXA was performed at the Uni-
versity Hospital of Brasilia on equipment branded Lu-
nar DPX NT (GE Medical Systems, Waukesha, Wis-
consin, USA). The performance of the densitometries 
of the whole body, lumbar spine, femoral neck, total 
hip, and 33% radius non-dominant followed the manu-
facturer’s instructions and were performed by the same 
operator. The results of the bone densitometry were 
expressed in g/cm2 and T-score, calculated by the de-
vice itself, and analyzed according to the criteria of the 
World Health Organization (10). A whole body DXA 
scan was also performed to measure total lean mass, 
lean mass of arms and legs, and fat mass using fan 
beam technology. The analyses were performed by a 
single doctor with the Encore 2005 program, version 
9.1, according to the manufacturer’s standards and re-
specting the standards of The International Society for 
Clinical Densitometry (ISCD). During the measure-
ments, all patients wore light cotton clothes without 
underwire bras, metal buttons, zippers, metallic paint, 
or threads. Precision values were calculated based on 
the short-term, in vivo precision study in which dupli-
cate measurements were performed with repositioning 
 between each scan in the 30 elderly men. A daily quality 
assurance scan was conducted by scanning an alumi-
num spine phantom according to the manufacturer’s 
instructions.
The coefficients of variation (CVs) of the lumbar 
spine BMD, the femoral neck BMD, total hip BMD, 
lean mass and fat mass measurements were 1%, 1.6%, 
1.8%, 0.74% and 1.5%, respectively.
Muscle components 
Appendicular lean mass (aLM (kg)) was determined by 
the sum of arms and legs lean mass (11). 
The relative appendicular skeletal muscle mass 
(RASM) was obtained from the aLM/height² (kg/m²) 
(12). 
The total skeletal muscle (TSM) mass is the soft tis-
sue mass, fat-free, bone, viscera, and internal organs. 
The TSM was estimated by aLM x 1.33 (kg) (13,14). 
Diagnosis of osteoporosis and sarcopenia
The criteria for densitometry diagnosis of pre-sarcope-
nia and sarcopenia obeyed the World Health Organiza-
tion (WHO) criteria and the definitions of the EWG-
SOP, respectively (8,10). Osteoporosis was defined as 
femoral neck, total hip, or lumbar spine having a T-
score lower than or equal to -2.5 SD, osteopenia was 
defined as a T-score more than -2.5 but less than -1.0, 
and normal BMD was defined as a T-score equal to or 
more than -1.0. The abnormal BMD group included 
both osteoporosis and osteopenia subjects.
According to the EWGSOP, sarcopenia can be sub-
classified into three categories, depending on the stage 
of the disease: pre-sarcopenia (characterized by low 
muscle mass, without any decrease in muscle strength 
or physical performance); sarcopenia (defined by re-
duction in muscle mass accompanied by a deteriora-
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tion of strength or physical performance); and severe 
sarcopenia (defined by the combination of low muscle 
mass, physical performance and muscle strength) (8). 
This study did not measure severe sarcopenia.
Low muscle mass was defined as RASM (aLM/
height²) below a threshold of 7.26 kg/m² (12).
The muscle strength was assessed by handgrip 
strength. To measure the handgrip strength, a dyna-
mometer was used (Takeikiki Kogyo, Japan, model 
T-2) with a capacity of 100 kgf and divisions of 1 kgf, 
adjustable and calibrated with a scale of 0 to 50 kg. 
Three measurements of maximum strength were ta-
ken at both sides, and the highest value was recor-
ded as maximal handgrip strength (8). Low muscle 
strength was defined as handgrip strength at ≤ 29 kg 
if BMI is ≤ 24, ≤ 30 kg if BMI is 24.1-28 and ≤ 32 kg 
if BMI is > 28.
STATISTICAL ANALySIS
Statistical analyses were performed using the SPSS sta-
tistical software (17th version; SPSS Inc., Chicago, IL).
Descriptive and association analyses showed the 
measurements of variables among sarcopenia diagnoses 
(normal, pre-sarcopenia, and sarcopenia) using analysis 
of variance (ANOVA) and abnormal BMD diagnosis 
using analysis of variance (T-Test). 
Multivariable linear regression analyses with BMD 
as a dependent variable were performed to identify the 
determinants for BMD among potential factor adjust-
ments for age and body weight. The results of all multi-
ple linear regression analyses expressed as β coefficients 
or standardized β coefficients and 95% confidence in-
tervals (CI). 
Regression analyses were used to examine the in-
fluence of lean mass, appendicular lean mass, relative 
appendicular skeletal muscle mass, the total skeletal 
muscle, fat mass, and grip strength on abnormal BMD 
diagnosis. Regression analysis tested the relationship 
between pre-sarcopenia and sarcopenia and diagnosis 
of abnormal BMD with results expressed as odds ratios 
(OR) and 95% CI. 
RESULTS
One hundred and ninety-eight men with a mean age 
of 68.3 years (SD = 6.8), mean body weight of 68.2 
kg (SD = 10.8), mean height of 1.63 m (SD = 0.06), 
and BMI mean of 25.44 (SD = 3.24) kg/m2 were eva-
luated. 
We found that 17 men (8.6%) had a diagnosis of 
diabetes. Only one man had been diagnosed with dia-
betes and sarcopenia.
Only 12.6% of the patients had a diagnosis of pre-
sarcopenia and 10.1% had a diagnosis of sarcopenia. 
According to table 1, we can see that men diagnosed 
with sarcopenia have lower BMD and T-score of the 
femoral neck compared to men with normal diagnosis. 
Sarcopenia and osteoporosis in men
Table 1. Anthropometric, grip strength and body composition analyses of 
normal, pre-sarcopenic and sarcopenic groups according to the definition 
of the EWGSOP
Normal  




( ± DP) 
(n = 25)
Sarcopenia  
( ± DP)  
(n = 20)
Age (years) 67c 67c 76a,b
Weight (kg) 69,80 ± 9,94b,c 63,10 ± 13,22a 62,15 ± 10,05a
Height (m) 1,63 ± 0,6 1,64 ± 0,06 1,61 ± 0,06
BMI (kg/m2) 26,04 ± 3,18b,c 23,18 ± 3,84a 23,70 ± 3,37a
% fat mass 25,45 ± 6,71 24,09 ± 9,56 25,94 ± 9,49
Total fat mass (kg) 17,16 ± 6,14 14,26 ± 7,24 15,73 ± 8,14
Lean mass (kg) 48,78 ± 5,10b,c 41,89 ± 4,20a 41,82 ± 3,73a
TSM (kg) 29,01 ± 3,22b,c 23,76 ± 1,88a 23,35 ± 2,52a
aLM (kg) 21,81 ± 2,42b,c 17,87 ± 1,41a 17,55 ± 1,89a
RASM (kg/m2) 8,14 ± 0,58b,c 6,60 ± 0,52a 6,70± 0,53a
Grip strength 
dominant (kgf)
35,16 ± 5,40c 34,92 ± 4,36c 24,82 ± 4,81a,b
Grip strength 
non-dominant (kgf)
34,55 ± 6,03c 33,70 ± 4,20c 25,28 ± 5,60a,b
Femoral neck 
BMD (g/cm2)
0,913 ± 0,123c 0,862 ± 0,118 0,789 ± 0,110a
T-Score of femoral 
neck
-1,17 ± 0,96c -1,60 ± 0,91 -2,12 ± 0,88a
Total hip BMD  
(g/cm2)
0,966 ± 0,19 0,908 ± 0,13 0,854 ± 0,11
T-Score of total hip -0,83 ± 0,92b,c -1,33 ± 0,93a -1,71 ± 0,77a
Lumbar spine 
BMD (g/cm2)
1,026 ± 0,15 0,989 ± 0,16 0,966 ± 0,132
T-Score of L1-L4 -1,54 ± 1,32 -1,92 ± 1,38 -2,03 ± 1,14
33% radius BMD 
(g/cm2)
0,736 ± 0,82 0,730 ± 0,91 0,699 ± 0,77
T-Score of 33% 
radius
-0,86 ± 0,95 -0,91 ± 1,12 -1,32 ± 0,96
BMI: body mass index; aLM: appendicular lean mass; RASM: relative appendicular skeletal 
muscle mass; TSM: total skeletal muscle.
Normal, Pre-sarcopenia and sarcopenia according to the EWGSOP (15).
a ANOVA; p < 0,05 = difference between means statistically significant in the normal group.
b ANOVA; p < 0,05 = difference between means statistically significant in the pre-sarcopenia 
group.
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Non-sarcopenic men have higher T-score of the total 
hip compared to men diagnosed with pre-sarcopenia 
and sarcopenia. There was no significant difference be-
tween BMD and T-score at the lumbar spine and 33% 
radius among non-sarcopenic, pre-sarcopenic, and sar-
copenic men.
Regarding the densitometric diagnosis, only 18.7% 
of the evaluated subjects had normal diagnosis. Pa-
tients with abnormal BMD (81.3%) had significantly 
lower height, body weight, BMI, and grip strength in 
the dominant hand, lean mass, appendicular lean mass, 
RASM, total skeletal muscle mass, and fat mass when 
compared to patients with normal diagnosis. Results 
are shown in table 2.
Table 2. Age, anthropometric, grip strength and body composition 
characteristics of normal and abnormal BMD groups
Normal group




Mean ± SD 
(n = 161)
Age (years) 67 ± 5,9 68 ± 6,2
Weight (kg) 73,25 ± 10,83* 67,02 ± 10,46*
Height (m) 1,65 ± 0,08* 1,63 ± 0,05*
BMI (kg/m2) 26,62 ± 2,45* 25,17 ± 3,34*
Grip strength dominant (kgf) 35,41 ± 6,67 33,02 ± 5,89
Grip strength non-dominant (kgf) 35,61 ± 7,77* 33,02 ± 5,97*
Lean mass (kg) 49,69 ± 6,69* 46,64 ± 5,28*
aLM (kg) 22,33 ± 3,16* 20,55 ± 2,66*
RASM (kg/m2) 8,11 ± 0,63* 7,73 ± 0,87*
TSM (kg) 29,71 ± 4,20* 27,34 ± 3,54*
Fat mass (kg) 19,00 ± 6,04* 16,11 ± 6,56*
%fat 27,22 ± 5,98 24,89 ± 7,65
BMI: body mass index; aLM: appendicular lean mass; RASM: relative appendicular skeletal 
muscle mass; TSM: total skeletal muscle.
Abnormal BMD group included both osteoporosis and osteopenia subjects.
Test t; p < 0,05 = difference between means statistically significant.
Sarcopenia and osteoporosis in men
Table 3. Association of anthropometric, grip strength, body composition and bone density: multivariable model
Femoral neck BMD Total hip BMD Lumbar Spine BMD 33% radius BMD non-dominant
Age (years) 0,0017 (0,0000;0,0033) 0,0017(-0,0009;0,0042) 0,0074 (0,0056;0,0092) 0,0035 (0,0022;0,0047)
Weight (kg) 0,0042 (0,0024;0,0060) 0,0092 (0,0057;0,0127) 0,0041 (0,0019;0,0063) 0,0015 (0,0001;0,0029)
RASM (kg/m2) 0,0632 (0,0433;0,0831) 0,1058 (0,0644;0,1463) - 0,0268 (0,0106;0,0431)
Lean mass (kg) - -0,0132 (-0,0216;-0,0048) - -
Grip strength dominant (kgf) - - 0,0068 (0,0030;0,0106) 0,0053 (0,0030;0,0076)
R2 for the model 0,983 0,967 0,978 0,987
RASM: relative appendicular skeletal muscle mass.
Results expressed as β coefficients and 95% CI. Stepwise linear regression including age, weight, height, BMI: lean mass, appendicular lean mass, relative appendicular skeletal muscle mass, total 
skeletal muscle, fat mass and grip strength.
Adjusted for age and weight.
To estimate and explain the variability of BMD’s 
femoral neck, total hip, lumbar spine, and 33% radius 
by means of the variables studied, a model of linear re-
gression, presented in table 3, was created. The models 
constructed explain 98% of the variability of bone mi-
neral densities. To select the variables that would make 
the model, the Stepwise method was used, and the 
models were adjusted for age and weight. Multiple li-
near regression analyses showed that relative appendic-
ular skeletal muscle mass, lean mass, and grip strength 
in the dominant hand were a positive significant deter-
minant factor for BMD in elderly men after adjusting 
for age and body weight.
Through logistic regression analysis, this study 
evaluated the influence of the variables in the diagnosis 
of abnormal BMD compared to patients with normal 
densitometric diagnosis. The results are presented in 
table 4. 
The results of regression analyses for abnormal 
BMD are shown in table 4 and allow us to infer that 
each year, elderly men increases the chances of a di-
agnosis of abnormal BMD by 5.8%. Together, the 
variables that composed the regression model for 
the diagnosis of abnormal BMD explained 51.7% of 
the variability. This result was obtained from the R2 
model. The results of regression analyses for abnormal 
BMD are shown in table 4. The study also evaluated 
the odds ratio of a men diagnosed with pre-sarcopenia 
and sarcopenia, presenting the diagnosis of abnormal 
BMD. The results show that men with pre-sarcopenia 
are about 8 times more likely to have a diagnosis of 
abnormal BMD compared to normal men. Men with 
sarcopenia see the chance increase by 9-fold. The re-
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Table 4. Regression analyses of body composition and muscle strength of 
abnormal BMD diagnosis, adjusted for age and weight
Odds Ratio and Confidence Interval (95%)
Abnormal BMD
Age (years) 1,058 (1,010;1,108)
Weight (kg) 0,969 (0,922;1,018)
Lean mass (kg) 1,169 (0,953;1,435)
aLM (kg) 0,649 (0,407;1,034)
RASM (kg/m2) 1,218 (0,616;2,408)
aLM: appendicular lean mass; RASM: relative appendicular skeletal muscle mass.
Abnormal BMD defined for men with T-score < -1,0.
Table 5. Regression analysis of pre-sarcopenia and sarcopenia of 
abnormal BMD diagnosis adjusted for age and weight









R2 of the model 0,096
Abnormal BMD was defined for men with T-score < -1,0.
Pre-sarcopenia and sarcopenia according to the EWGSOP (15).
Sarcopenia and osteoporosis in men
sarcopenia are more likely to have a higher risk of os-
teopenia and osteoporosis.
The association between sarcopenia and bone mass 
demonstrated in this study is consistent with the hy-
pothesis of previous studies showing a reduction in os-
teogenic effect due to a minor mechanical stimulation 
imposed on the bone structure by reducing the muscle 
and muscle function (4,6,15). Another point would be 
the reduction of the mechanical stimuli from less physi-
cal activity due to a lower functional capacity of the 
elderly caused by sarcopenia (12). However, studies to 
evaluate the mechanisms leading to sarcopenia to pro-
pitiate a lower bone mass are needed for more effec-
tive clinical practice for the prevention and treatment 
of osteoporosis in the male population. It has been 
estimated that the prevalence of osteoporosis in men 
varies between 1 and 4% of the population, and that 
15-33% of men have osteopenia (20,21). In contrast, in 
the present study sample, 33.8% of men evaluated were 
diagnosed with osteoporosis and 47.5% with osteope-
nia, totaling 81.3% of the sample with abnormal BMD. 
These findings may reflect greater difficulty in compar-
ing our findings with those of other studies.
Our study found that 12.6% of the sample had a 
diagnosis of pre-sarcopenia and 11.9% had a diagnosis 
of sarcopenia. Another study showed similar results and 
diagnosed pre-sarcopenia in 10.1% and sarcopenia in 
3.7% of the sample (4). 
Our study also investigated the relationship between 
the components of the criteria for sarcopenia and BMD 
independently. We verified that the RASM and lean 
mass were the independent variables that best explained 
the variability of BMD’s femoral neck, total hip, and 
radio 33% non-dominant. Similar findings were also ob-
served in the study by Cui and cols. which, after evalu-
ation of 445 men (Koreans) aged above 50 years (mean 
62.7 years), found that lean mass, evalua ted by DXA, 
was significant to explain the variability of BMD of lum-
bar (b = 0.271; p = 0.004), femoral neck (b = 0.446; p 
= 0.000), and 33% radius (b = 0.281; p = 0.001) (22). 
We also observed this relationship in the study of Kirch-
engast and Huber, which after evaluation of 130 men 
aged 60-92 years, found a significant positive associa-
tion between RASM and total body BMD and femo-
ral neck (23). These results, although not conclusive, 
suggest that the increase in muscle mass will provide a 
gain in bone mass in elderly men, which encourages the 
development of further studies to evaluate the effect of 
exercise training programs, diets, and clinical interven-
DISCUSSION
Pre-sarcopenia and sarcopenia, characterized by a loss 
of muscle mass and muscle strength, are two of the 
main conditions responsible for the reduced functional 
capacity of the individual during aging, which may rep-
resent a negative influence on bone mineral density, as 
well as increased probability of the patient having a di-
agnosis of osteoporosis (15,16). However, studies have 
shown contradicting associations, in relation to pre-
sarcopenia and sarcopenia, with BMD and diagnosis of 
osteoporosis (17,18). Coin and cols., after evaluation 
of 136 men (mean age 73 years), found no significant 
association between BMD of the femoral neck and to-
tal hip with RASM < 7.26 kg/m², that is, diagnosed 
with pre-sarcopenia according to the EWGSOP (8,19). 
More recently, Verschueren and cols. found that men 
with pre-sarcopenia and sarcopenia were more likely to 
have osteoporosis compared with those with normal 
RASM (odds ratio 3.8; 95% CI01.6-9.1 and 3.0; 95% 
CI01.6-5.8 respectively) (4). Similarly, our results also 
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tions directed to the increase muscle mass with the goal 
to prevent and treat the loss of BMD in elderly men and 
thus decrease the risk of osteoporotic fractures.
Another essential component for the diagnosis of 
sarcopenia is muscle strength. Handgrip strength is 
one of the muscular strength tests suggested by the 
EWGSOP to set the diagnosis of sarcopenia, as a me-
thod that is easy to apply, relatively inexpensive, and has 
a good relation with systemic muscle strength (8). In 
our study, we found that the higher handgrip strength 
in the dominant hand was associated with higher lum-
bar spine BMD and 33% radius BMD, presenting a 
relationship as systemic as site specific with the BMD. 
A positive association between handgrip strength and 
lumbar spine BMD, may be related to osteophytes. In 
a study conducted with 234 men with a mean age of 
47.8 years, grip strength was not shown to be a good 
systemic predictor of BMD, being considered non-
significant for predicting the femoral neck and lum-
bar BMD after stepwise linear regression analysis (24). 
These results suggest that the practice of physical activi-
ties that provide increased handgrip strength can also 
increase the radius BMD 33%, thus reducing the risk of 
wrist fractures in elderly men. New studies are needed 
to confirm this assumption.
Some authors evaluated the effect of fat mass on 
BMD in men. A study with 144 Korean men, aged 20 
to 88 years, found that the mass of total body fat, ap-
pendicular fat mass, cholesterol (HDL and LDL), and 
triglycerides were not significant in explaining the vari-
ability of lumbar BMD (L1 - L4) (25). Similar find-
ings were observed in the study of Kirchengast and 
cols. which, after evaluation of 62 men aged between 
60 and 86 years, showed that fat mass, measured by 
DXA, was not significantly associated with BMD of the 
femoral neck (26). In our study, although the group of 
men diagnosed with abnormal BMD possessed signifi-
cantly lower fat mass in relation to the group of men 
with normal BMD, the fat mass was not significant in 
predicting the variability of BMD. These findings indi-
cate that fat mass, independently and after adjusting for 
body weight, has no effect on BMD, and possibly its 
influence is given only for their contribution in weight. 
More studies are needed to prove this theory.
The originality of this study lies in being the first 
work on the Brazilian population that used the defini-
tion proposed by the EWGSOP to distinguish sarcope-
nic men from normal men.
This study has several limitations. First, it is a cross 
sectional study. Longitudinal studies with intervention 
are needed to confirm whether increasing muscle mass 
increases BMD and a smaller risk for abnormal BMD 
diagnostic. Others limitations of our study would be 
the size and regionalization of the sample, which does 
not allow us to make inferences about the relation-
ship between pre-sarcopenia, sarcopenia, and abnor-
mal BMD in other populations. The lack of studies in 
the Brazilian population to verify the effectiveness of 
points cohort for RASM and grip strength, suggested 
by EWGSOP to distinguish Brazilian men with normal 
diagnosis from men diagnosed with pre sarcopenia and 
sarcopenia, may have influenced the assessment of the 
effect of pre-sarcopenia, sarcopenia, and the abnormal 
diagnostic and BMDs.
We suggest further studies, with more patients, so 
that the relationship between pre-sarcopenia, sarcope-
nia, and bone health may be better understood.
We conclude that elderly men diagnosed with pre-
sarcopenia and sarcopenia are more likely to display ab-
normal BMD. After adjusting for risk factors, RASM 
and lean mass were the independent variables that best 
explained the variability of BMD’s. Elderly men with 
RASM at < 7.26 kg/m² had significantly lower BMD 
compared with those with RASM at ≥ 7.26 kg/m2.
Our results support the need to develop programs 
aimed at preventing the reduction of muscle mass and 
strength in order to avert the reduction in bone mineral 
density and consequently osteoporosis. 
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